DJIA 17,876.65 48.90 0.27%
NASDAQ 4,807.44 20.12 0.42%
S&P 500 2,073.17 0.34 0.02%
market minute promo

BioMarin Pharmaceuticals (NASDAQ: BMRN)

89.48 0.10 (0.11%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BMRN $89.48 0.11%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $89.47
Previous Close $89.38
Daily Range $88.92 - $90.83
52-Week Range $55.04 - $91.40
Market Cap $13.2B
P/E Ratio -101.57
Dividend (Yield) $0.00 (0.0%)
Volume 246,354
Average Daily Volume 1,193,672
Current FY EPS -$1.06

Sector

Healthcare

Industry

Drugs

BioMarin Pharmaceuticals (BMRN) Description

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Website: http://www.bmrn.com/

News & Commentary Rss Feed

BioMarin Takes Aim at Sarepta

BioMarin's acquisition of Prosensa puts it in direct competition with Sarepta.

Health Care Sector Update for 11/26/2014: SRPT,RNA,BMRN,BDX,MRGE

Biotech Stock Roundup: BioMarin to Acquire Prosensa, AbbVie HCV Therapy Closer to EU Approval - Anal

Biotech Stock Roundup: BioMarin to Acquire Prosensa, AbbVie HCV Therapy Closer to EU Approval - Analyst Blog

Prosensa Soars on $680M Buyout Offer from BioMarin - Analyst Blog

Prosensa Soars on $680M Buyout Offer from BioMarin - Analyst Blog

Rolling With Biotech's Regulatory Punches: Chen Lin

New Lifetime High Today: Biomarin Pharmaceutical (BMRN)

RBC Has Three Top Biotech Picks for Year End and 2015

Benzinga's M&A Chatter for Monday November 24, 2014

Closing Update: Stocks Extend Winning Streak to Third Day

S&P 500 Little Changed Amid Uncertainty Over U.S. Economic Growth

See More BMRN News...

BMRN's Top Competitors

BMRN $89.48 (0.11%)
Current stock: BMRN
AMGN $165.68 (0.58%)
Current stock: AMGN
GILD $101.00 (0.70%)
Current stock: GILD
BIIB $309.74 (1.58%)
Current stock: BIIB